Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)

SHE:300942 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	271.53	263.23	224.25	254.11	686.9	597.54
Revenue Growth	14.51%	17.38%	-11.75%	-63.01%	14.95%	131.20%
Gross Profit Gross Profit Growth	172.37	166.04	156.1	96.19	341.89	426.16
Operating Income Operating Income Growth	13.91	15.5	16.45	-114.47	72.76	248.1
Net Income Net Income Growth	6.83	13.74	17.12	-184.91	82.97	236.51
Earnings Per Share EPS Growth	0.01	0.03	0.04	-0.46	0.21	0.60
EPS Growth	-69.46%	-25.00%	-	-	-65.00%	233.33%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Food Rapid Testing Business Food Rapid Testing Business Growth	237.43	208.51	198.03	184.94	182.53
Animal Disease Detection Animal Disease Detection Growth	14.46	13.74	8.39	2.51	-
Park Operation Services Park Operation Services Growth	11.34	-	-	-	-
in Vitro Diagnostic Business in Vitro Diagnostic Business Growth	-	2	47.69	499.44	415.01
Total Total Growth	263.23	224.25	254.11	686.9	597.54

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	599.66	628.13	596.31	601.78	429.36	682.42
Total Debt Total Debt Growth	461.49	447.55	467.98	365.87	119.34	41.12
Net Cash (Debt) Net Cash Growth	138.17	180.59	128.33	235.91	310.02	641.31
Net Cash Growth	30.42%	40.72%	-45.60%	-23.91%	-51.66%	69.17%
Net Cash Per Share Net Cash Per Share Growth	0.30	0.39	0.30	0.59	0.78	1.63

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	55.76	66.87	34.26	-37.25	152.55	255.42
Capital Expenditures CapEx Growth	-63.69	-45.9	-174.1	-128.64	-176.85	-79.51
Free Cash Flow Free Cash Flow Growth	-7.93	20.97	-139.85	-165.89	-24.29	175.92
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	63.48%	63.08%	69.61%	37.85%	49.77%	71.32%
Operating Margin	5.12%	5.89%	7.34%	-45.05%	10.59%	41.52%
Pretax Margin	1.93%	5.05%	8.78%	-69.97%	13.81%	44.86%
Profit Margin	2.51%	5.22%	7.63%	-72.77%	12.08%	39.58%
FCF Margin	-2.92%	7.97%	-62.36%	-65.29%	-3.54%	29.44%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Dividend Per Share Dividend Per Share Growth	0.025	0.025	0.017	-	0.021	0.249
Dividend Per Share Growth	41.51%	41.51%	-	-	-91.49%	453.33%
Dividend Yield	0.39%	0.26%	0.21%	-	0.13%	0.88%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	388.48	277.35	200.71	-	82.81	48.92
P/FCF Ratio	-	181.75	-	-	-	65.76
PS Ratio	9.77	14.48	15.32	18.44	10.00	19.36

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error